AKBA (AKBA) Stock Price & Analysis
AKBA (AKBA) fell 0.87% to USD 0.97 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
AKBA last closed at USD 0.97; the session ranged USD 0.95–1 on volume of 8,347,916 shares. Market capitalization is —, with a 52-week range of USD 0.81–3.2 (NCM). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 0.97 |
|---|---|
| Change | ▼ 0.87% (down) |
| Previous Close | USD 0.97 |
| Open | USD 0.97 |
| Day Range | USD 0.95 – 1 |
| 52-Week Range | USD 0.81 – 3.2 |
| Volume | 8,347,916 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (AKBA)
Nexqual's technical model rates AKBA "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 46.16 (neutral) |
| vs SMA50 | Below (USD 1.13) |
| MACD | -0.04 (negative) |
From AKBA's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ARDX | Ardelyx, Inc. | USD 3.78 | ▼ 0.53% |
| KYNB | Kyntra Bio, Inc. | USD 8.55 | ▲ 0.23% |
| KPTI | Karyopharm Therapeutics Inc. | USD 1.79 | ▲ 0% |
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| ABEO | Abeona Therapeutics Inc. | USD 6 | ▲ 0.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.